Gross-total resection (GTR), near-total resection (NTR), and subtotal resection (STR) are widely used descriptive terms 8 that refer to intraoperative findings; in each case in our series the extent of resection was confirmed by means of postoperative MR images (obtained an average of 220.7 days after surgery). We classified each case as GTR, NTR, or STR, according to the intraoperative findings and postoperative MR imaging findings, defined in terms of the Simpson grading system: 17 GTR matches Simpson Grade I and II, defined as showing no intraoperative evidence of residual tumor and no evidence of contrast-enhancing tumor on postoperative MR images; NTR matches Simpson Grade III, defined as 1) intraoperatively observed residual tumor despite negative postoperative imaging, 2) extracavernous enhancing tumor < 1 cm 3 on postoperative contrastenhanced axial images, and/or 3) persistent or residual CS tumor of any volume. The designation STR matches Simpson Grade IV and V and was defined as > 1 cm 3 of extracavernous residual enhancing tumor on postoperative MR images.
Neurosurgeons do not routinely resect tumors in the CS. Meningiomas in the CS can directly infiltrate CNs and spread via direct extension along the connective tissue planes 15 between them. Manipulation of the CNs in the CS increases the risk of permanent postoperative deficits. Finally, the regrowth rate is quite small for residual meningioma in the CS, 2, 3, 5, 16 and radiosurgery is an effective and safe treatment for it. 1, 6, 10, 18 We evaluated all the patients' KPS scores and neurological symptoms both pre-and postoperatively. We also monitored their KPS scores and neurological symptoms through our outpatient service (mean [± SD] duration of follow-up 1350 ± 1090 days). We defined the improvement of symptoms as an increased KPS score and postoperative deterioration of the patient's condition as a decreased KPS score.
Statistical Analysis
The statistical analyses were performed separately for the derivation of the risk factors and the validation of the risk scores. For the derivation step, data were collected retrospectively in 132 consecutive cases of SBM involving patients who were first treated surgically between May 2000 and December 2005. For the validation step, data were collected in 60 consecutive cases of SBM in which patients were treated with primary or repeated surgery between January 1995 and April 2000. The same statistical tools were used in both steps.
First, 13 candidate items were evaluated for differences between the GTR, NTR, and STR groups, using the Mann-Whitney U-test. Statistical significance was defined as a probability value < 0.05. Items showing significant differences between groups were further evaluated by a stepwise multiple regression model. The value of the standard regression coefficient reflects the strength of the correlation. Differences among 3 means were analyzed using the Kruskal-Wallis test. We also used linear regression, and calculated the Pearson correlation coefficient (partial correlation matrix) for the evaluation of the ABC surgical risk score and grade in relation to the extent of tumor removal, tumor location, and neurological change after surgery. All the quantified data are expressed as means ± SDs.
Derivation of a Simple Risk Score
To evaluate potential items for inclusion in the surgical risk score for SBM, we first identified 13 candidate items: 1) preoperative symptoms (none, CN symptoms only, CN symptoms with long tract sign); 2) major axis of the tumor; 3) attachment size (largest diameter on MR images, in centimeters); 4) tumor located mainly in the anterior, middle, or posterior cranial fossa; 5) tumor located in single or multiple cranial fossae; 6) central cavity location (that is, tumor located within, partially within, or outside the space defined by CN II-XII; Fig. 1 left) ; 7) CN involvement (CNs classified into 4 groups, assessment was for involvement with 0, 1, or ≥ 2 groups; Fig. 1 right) ; 8) arterial involvement (0, 1, or ≥ 2 arteries); 9) brainstem contact (CSF space visible on MR imaging, no visible CSF space, or perifocal edema and no visible CSF); 10) extracranial invasion; 11) tumor consistency (hard or soft, based on T2-weighted MR images 9, 19, 20 ); 12) preoperative radiosurgery; and 13) preoperative embolization. Data for all of these items were available at the time of the preoperative evaluation and could be tested statistically for correlation with the extent of resection.
Retrospective data from 132 consecutive patients with SBMs who were first treated surgically between May 2000 and December 2005 in the Department of Neurosurgery, School of Medicine, Keio University were used to choose the risk factors for the extent of tumor removal and patient outcome. We evaluated only primary surgery cases for this purpose.
The cases involved 34 male and 98 female patients with a mean age of 54.6 ± 12.3 years. The mean follow-up period was 831 ± 211 days. The location of the SBM was the anterior cranial fossa in 22% of the cases, the anterior and middle cranial fossae in 9.1%, the middle cranial fossa in 9.8%, the middle and posterior cranial fossae in 14.4%, the posterior cranial fossa in 43.2%, and the anterior, middle, and posterior cranial fossae in 1.5%. The extent of tumor resection was GTR in 63.5% of the cases, NTR in 9.4%, and STR in 27.1%.
Validation of ABC Surgical Risk Scale
We next applied our scoring system to 60 consecutive cases of SBM treated by primary or repeated surgery between January 1995 and April 2000. This group of cases involved 11 male and 49 female patients, with a mean age of 52.6 ± 10.3 years. The mean follow-up period was 2440 ± 1102 days. The major location of the SBM was the anterior cranial fossa in 27.9% of the cases, anterior and middle cranial fossae in 3.3%, middle cranial fossa in 11.5%, middle and posterior cranial fossae in 13.1%, posterior cranial fossa in 37.7%, and anterior, middle, and posterior cranial fossae in 3.3%. The extent of resection was GTR in 63.3% (38 cases), NTR in 23.3% (14 cases), and STR in 13.3% (8 cases) . In this series, the posterior fossa was the most common location of the SBM, just as in the previous series.
Results

Derivation of a Simple Risk Score
Statistical analysis demonstrated no significant differences for 5 items (extracranial invasion, tumor located in single or multiple cranial fossae, tumor consistency, preoperative radiosurgery, and preoperative embolization) using the Mann-Whitney U-test, or for 3 more items (preoperative symptoms, major axis of tumor, and tumor located mainly in the anterior, middle, or posterior cranial fossa) using the stepwise multiple regression model. Stepwise multiple regression analysis showed significant differences for the last 5 items (attachment size, arterial involvement, brainstem contact, central cavity location, and CN involvement; Table  1 ). Therefore, we included these 5 items as factors in the surgical risk score: attachment size, arterial involvement, brainstem contact, central cavity location, and CN involvement. We named this system the ABC Surgical Risk Scale after the initial letters of these 5 items.
The ABC Surgical Risk Scale
In constructing the scale, each of the 5 factors was scored on a scale of 0-2 points. Although the predictive variables in the score were derived from data on primary surgeries, to take into account the practical effects of patients' treatment histories during validation and clinical use of the scale, 1 point each for previous surgery or radiation treatment was added as part of the scoring system. The maximum possible score was thus 12 points (Fig. 2) .
The T2-weighted MR images were sufficient for evaluating both arterial involvement and brainstem contact, because arterial involvement appears as an intratumoral flow void, and the positional relationship is readily detectable between the brainstem and SBM according to whether CSF space is visible, not visible, or not visible and perifocal edema is present.
Attachment Size. Attachment size was defined as the largest diameter on axial, coronal, or sagittal MR images, measured in centimeters, and scored as follows: ≤ 2 cm, 0 points; 2-4 cm, 1 point; and ≥ 4 cm, 2 points. The mean attachment size was 3.2 ± 1.5 cm for all cases. In GTR cases the mean attachment size was 2.6 ± 1.2 cm, in NTR cases it was 2.9 ± 0.8 cm, and in STR cases it was 4.1 ± 1.6 cm (Fig. 3A) .
Arterial Involvement. Arterial involvement was scored as follows: no involvement, 0 points; 1 artery involved, 1 point; and multiple arteries involved, 2 points. In 77.5% of the GTR cases there were no involved arteries. In contrast, there was single or multiple artery involvement in 80% of the NTR cases and 94.4% of the STR cases; 58.3% of the STR cases had multiple artery involvement. The standard regression coefficient was 0.328; arterial involvement showed the second highest and second strongest effect values for the extent of SBM removal among the 5 items (Table 1 , Fig. 3B ).
Brainstem Contact. Brainstem contact was scored as follows: visible CSF space on MR images, 0 points; no visible CSF space, 1 point; and perifocal edema and no visible CSF space, 2 points. In 88.8% of the GTR cases CSF space was visible between the brainstem and the SBM. (See Fig.  3C for comparison with NTR and STR.) In our data from May 2000 on, we did not see any GTR cases of tumor with perifocal edema (Table 1 , Fig. 3C ). Brainstem contact was the only factor of the 13 original evaluation items to show a significant correlation with postoperative neurological changes in the stepwise multiple regression models (data not shown).
Central Cavity. Location with respect to the central cavity was scored as follows: tumor completely outside the cavity, 0 points; partial involvement of the cavity, 1 point; and tumor mostly within the cavity, 2 points. The central cavity is a concept defined here for the first time. It is the space at the base of the skull delimited by the dural entry of CN II-XII (Fig. 1 left) . Skull base meningiomas that were located completely outside this space were defined as "outside" the central cavity (boundaries shown in Fig. 1 left) . If the bulk of a given lesion lay largely within the boundaries it was defined as "inside" the cavity; "partial involvement" describes SBMs that extended into the central cavity. This factor showed the greatest correlation with the extent of SBM resection (standard regression coefficient 0.371; Table 1 , Fig. 3D ).
Cranial Nerve Involvement. Cranial nerve involvement was scored as follows: no involvement, 0 points; single nerve groups involved, 1 point; and multiple nerve groups involved, 2 points. For this analysis, we divided the CNs into 4 groups. Group 1 contained only the optic nerve. Group 2 included the CNs from the oculomotor through the abducens nerve. Group 3 included the facial, cochlear, and vestibular nerves. Group 4 included the glossopharyngeal to the hypoglossal nerves (Figs. 1 right and 3E ). Each group was matched anatomically on the MR imaging and CT scans.
Validation of the Scale and Definition of Risk Grades
On average, the GTR cases scored 2.0 ± 1.3 points, NTR cases scored 6.1 ± 0.7 points, and STR cases scored 9 ± 0.5 points (Fig. 4A ). The differences in scores among these 3 groups were significant (p < 0.0001). We used these data to define 3 grades of surgical risk.
We defined Grade I cases as those scoring 0-4 points, Grade II as those scoring 5-7 points, and Grade III as Fig. 4B ).
A comparison of the ABC Surgical Risk Grade with tumor location showed that in Grade I cases, the SBM was located mainly in the anterior cranial fossa (48.5%) and middle cranial fossa (15.2%). However, in Grade II and, even more so, in Grade III cases, the percentage of tumors in the anterior and middle cranial fossa was lower and the percentage in the posterior cranial fossa was higher (p = 0.0002, Fig. 4C ).
Outcome of Surgery
In a separate study, we investigated the effect of the surgery on the patients' preoperative symptoms. For this evaluation, data were collected from all 192 consecutive cases of SBM treated with primary surgeries or retreated between January 1995 and December 2005. We found that with an increase in grade, fewer patients showed improvement in their preoperative symptoms and more showed deterioration postoperatively. Among the Grade I and II cases, a larger percentage of patients showed improvement rather than deterioration of preoperative symptoms. Of the Grade III cases, however, the percentage in which there was symptom deterioration exceeded that in which there was improvement (p < 0.0001, Fig. 4D ). These data suggested that the ABC Surgical Risk score indeed reflects real surgical risk, and in cases assigned < 8 points the likelihood of successfully removing the tumor is high, as is the chance of improvement in preoperative symptoms (Figs. 5 and 6).
Finally, we evaluated the association between the ex tent of tumor removal and postoperative neurological changes, because it is unclear how the extent of resection contributes to subsequent neurological deterioration.
In our study, there were 103 Grade I cases. Of these, neurological improvement was seen in 58 cases (56.3%) and neurological deterioration occurred in 8 (7.8%). In the Fig. 2 . The ABC Surgical Risk Scale. Attachment size refers to the greatest diameter on contrast-enhanced axial, sagittal, or coronal MR images. Brainstem contact is scored according to whether a CSF-filled space is visible between the tumor and brainstem on the T2-weighted MR image and whether perifocal edema is present when the CSF space has been lost. Tumor location relative to the central cavity (defined in Fig. 1 ) is a significant predictive variable. Cranial nerve involvement is scored by anatomical tumor extension along defined groups of CNs. (See text and Fig. 1 for details. ) 58 cases with neurological improvement, 2 surgeries were STR and the remaining 56 were GTR. In the 8 cases with neurological deterioration, only 1 surgery was NTR and the remaining 7 were GTR.
There were 57 Grade II cases; 29 (50.9%) showed neurological improvement, and 16 (28.1%) showed neurological deterioration. In the 29 cases showing neurological improvement, 6 surgeries were GTR and 13 were STR (10 were NTR). In the 16 cases with neurological deterioration, 6 surgeries were GTR and 2 were STR (8 were NTR).
There were 32 Grade III cases; 7 (23.3%) showed neurological improvement, and 14 (46.7%) showed neurological deterioration. In the 7 cases showing neurological improvement, no surgeries were GTR and 6 were STR (1 was NTR). In the 14 cases with neurological deterioration, no surgeries were GTR and 10 were STR (4 were NTR). The result of weighing neurological change against the extent of surgery suggested that extensive surgery causes neurological deterioration in Grade II and Grade III cases (Fig. 7) .
Discussion
Because of the deep location of SBMs and the possible involvement of arteries and CNs and of adhesion to the brainstem, it can be difficult to discern the best treatment strategy for a given case. The possibilities are surgery, radiation, and/or observation. The decision is complicated by the need for considerable skill and experience on the part of the surgeon, if surgery is selected. Thus, a protocol for weighing the risk factors for this surgery is needed both for predicting the extent of tumor removal and for anticipating the probable neurological outcome. A practical risk scale should be simple and easy to recall and should provide a straightforward preoperative determination. The ABC Surgical Risk Scale meets these criteria. A practical protocol for risk assessment will have tremendous benefits for the surgeon and patient because it will allow rational decisionmaking about the treatment that is most likely to minimize the risk of complications.
Other grading systems have been proposed to predict the extent of tumor removal and outcome for SBM surgery, 7, 13 but the method we describe in this paper specifically predicts the extent of tumor removal and postoperative neurological changes. Moreover, the previously proposed grading systems are not widely used. Currently, a CS-cen- tered grading system lacks utility, because intra-CS meningiomas are not usually treated by surgery. A grading system that does not take the lower CNs into account results in errors, because the surgery is most difficult when the SBM is located in the posterior cranial fossa. 7, 13 The benefit of focusing on the posterior cranial fossa in our scoring system is that many factors influence tumor removal in this space, which is the most tight and complex of the cranial fossae. In fact, the results of our study indicate that SBMs located in the posterior cranial fossa are the most difficult to resect (Fig. 4C) .
Our ABC Surgical Risk Scale was created using data from cases of primary surgery only, so it does not reflect confounding data from the more highly variable circumstances of repeated surgical treatment. For example, postoperative changes at the original tumor site can cause adhesions between the residual tumor and normal tissue, and frequently lead to the consolidation of adjacent tissues with the tumor. Furthermore, the success of repeated operations in removing residual tumor tissue is highly variable, and case-to-case variation with respect to other factors related to outcome is large as well. Nonetheless, we felt that we needed to take into consideration the potential for added risk in repeated surgery and the effect of preoperative radiation in designing our scoring system, particularly because the number of cases requiring reoperation or preoperative radiation is expected to increase and therefore to influence the extent of tumor removal. 7 For these reasons, we have added 1 point for previous surgery and 1 point for preoperative radiation in our scoring system.
Because the greatest number of SBMs occur in the surgically difficult posterior cranial fossa, we introduced a new anatomical concept in this paper-the central cavity (Fig. 1 right) . At first, we considered using the CN cavity, the space enclosed by CN I-XII, for assessing the effect of tumor location on surgical risk and outcome. However, we decided not to include CN I, partly because olfactory nerve function is usually not affected by tumor removal (anosmia is a preoperative symptom if the meningioma is located in the olfactory groove), and partly because if the olfactory nerve is sacrificed by the operation, the activities of daily living are not compromised very much, compared with the impact of losing the function of other CNs. Consequently, we developed the concept of the central cavity (Fig. 1 right) .
For our ABC Surgical Risk scoring system, we also created a classification scheme that divides the CNs into spatially and functionally related groups (Fig. 1 left) . This classification serves to simplify the analysis of CN involvement. The CNs are located in a very narrow area of the skull base where many SBMs arise and often involve a number of CNs. It is difficult, however, to identify accurately the CNs involved by a meningioma on the basis of preoperative MR imaging and neurological evaluation; it is much easier to identify nerves as originating within a spatially distinct group. Our positional and functional classification scheme was as follows: Group 1 (optic nerve), visual function; Group 2 (oculomotor, abducens, trigeminal, and trochlear nerves), ocular motility and facial sensory functions; Group 3 (facial, vestibular, and cochlear nerves), facial motor and hearing; and Group 4 (glossopharyngeal, vagus, accessory, and hypoglossal nerves), deglutition and vocal functions (Fig. 1 left) .
The 5 items that we identified as correlating significantly with the extent of tumor removal are reasonable factors for influencing the success of SBM surgery. Here, attachment size was defined as the greatest attachment diameter on the axial, sagittal, or coronal MR images, an easier measure to determine than area. Although it is common to record the maximum diameter of all kinds of tumors, the attachment size or area is more important in meningiomas, especially SBMs, because the attachment site is the target of the surgical approach, and the approach is constrained by the anatomy to a narrow and limited space.
Arterial involvement is accepted as a factor that makes surgery significantly more difficult. Nevertheless, the actual factor affecting extent of tumor removal is not so much the arterial involvement as the degree of adherence between the meningioma and the artery. In fact, even if the meningioma is tightly involved with an artery, we can sometimes perform a GTR. In the future, we may be able to replace arterial involvement with another more suitable factor that can be evaluated preoperatively to predict the degree of adhesion between the meningioma and any involved artery.
Kawase et al. 4 and Sekhar et al. 14 classified meningioma stages according to the relationship between the brainstem and the tumor. Stage 1 shows preservation of the arachnoid plane, which is seen as a high-intensity band between the meningioma and the brainstem on T2-weighted MR images. In their Stage 2 tumors, the arachnoid plane is lost, which is indicated by absence of the high-intensity band on T2-weighted MR images. In their Stage 3 tumors, the pial membrane has been destroyed and brainstem edema is present, which is seen as absence of the high-intensity band and presence of brainstem edema on T2-weighted MR images. Under Stage 3 conditions, tumor dissection damages the brainstem surface, because the pial tumor is supplied by a branch of the basilar artery 12 to which the tumor and brainstem are strongly adherent. 4, 14 As we have found with the ABC Surgical Risk Scale, these authors have also noted that cases with perifocal edema or those in which it is difficult to free the meningioma from the brainstem may best be treated by STR as the initial treatment strategy. 4, 14 Another argument for avoiding aggressive surgery for the complete resection of SBMs is that such surgery sometimes causes CN disorders or other complications.
11 In addition, surgery may be a less attractive treatment option in certain circumstances, some health-related, like a patient's age and physical condition (for example, cardiac or renal function), and some related to other considerations, such as the patient's socioeconomic situation. These limitations on surgical treatment highlight the need for a simple method to evaluate the likely cost-benefit outcome of performing this surgery.
Our ABC Surgical Risk Scale can be used to predict the likelihood of complete resection of a given SBM, and of a positive outcome in terms of an improvement in preoperative symptoms. Therefore, this scale can be very useful both for determining the best treatment modality for a given SBM case and for explaining the surgical risk to the patient. For example, our ABC system indicates that Grade I and Grade II SBMs should be treated with surgery rather than radiation, when possible, because complete dissection of the tumor and symptom improvement are likely, and the potential for clinical deterioration is low. However, in Grade III SBMs, STR is likely, and the rate of clinical deterioration is high (Fig. 4B and D) . Therefore, in cases of Grade III SBMs, it may be necessary to dissect only the portion of the tumor that can be safely removed and that is not treatable by postoperative radiosurgery, because an attempt to dissect such tumors completely carries a high probability of postoperative morbidity.
Conclusions
We developed a tool for assessing surgical risk in the treatment of SBMs, called the ABC Surgical Risk Scale. It represents a very simple and useful scoring method that can be quickly adopted in clinical practice for the preoperative prediction of the extent of tumor removal and surgery-related neurological changes. Use of this tool will allow surgeons to make informed decisions about the best treatment modality to offer their patients. Patients can benefit from the simplicity of this assessment tool, because it allows a clear explanation of the risk/benefit considerations involved in choosing a successful treatment.
Disclaimer
